Plain-English translation of NCT05072041 on ClinicalTrials.gov β Β· Source last updated Β· Translation generated Β· How we translate trials
This study doesn't follow the usual testing phases β it may be an observational study or a different type of research.
This trial is testing a new treatment for hepatocellular carcinoma (liver cancer) called Nexsphere, which uses special dissolvable beads. During a procedure, doctors inject these beads directly into the blood vessels that feed the tumor, combining chemotherapy with a blockage that stops blood flow to cancer cells. The study will track how safe this treatment is and how well it works to shrink tumors.
Current treatments for liver cancer can sometimes damage healthy liver tissue and cause side effects. This trial is testing whether the new dissolvable beads cause fewer complications while still effectively treating the cancer.
You likely qualify ifβ¦
You likely don't qualify ifβ¦
If you qualify, you will receive the treatment procedure, which involves a doctor inserting a catheter (small tube) into an artery and directing dissolvable beads mixed with chemotherapy directly to your liver tumors. After the procedure, you will be monitored for side effects like post-procedure syndrome (pain, fever, nausea) and for how well your liver is functioning. You will return for imaging scans and blood tests at 1 month to see how your tumors have responded and to check for any damage to the liver blood vessels.
AI-generated summary from trial data Β· Jun 13, 2026 Β· Not medical advice
South Korea
Sponsor
Next Biomedical Co., Ltd.
Enrollment target
~150 participants
Started
October 2021
Primary completion
August 2025
This trial's estimated completion date has passed β the record may not be fully up to date.
Age range
19 Years β 79 Years
Last updated on clinicaltrials.gov in November 2024.
Reach out to the team running this trial. Response times vary β some teams are faster than others.
Central contact
Jin Hee Maeng, MS
Asan Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first β no email needed to get started.